Long-tern prescribing of proton pump inhibitors in general practice

British Journal of General Practice

Volumn 49, Issue 443, 1999, Pages 451-453

  Hungin, A Pali S ^a   Rubin, Greg P ^c   O'Flanagan, Hilda ^b  

^a DURHAM UNIVERSITY   (United Kingdom)

^b Health Centre   (United Kingdom)

^c NONE

Author keywords

General practitioners; Prescribing; Proton pump inhibitors

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; PROTON PUMP;

ADULT; AGED; ARTICLE; CHRONIC PATIENT; DRUG COST; DRUG USE; DYSPEPSIA; FEMALE; GENERAL PRACTICE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; PEPTIC ULCER; PRESCRIPTION; REFLUX ESOPHAGITIS; UNITED KINGDOM; CLINICAL PRACTICE; DRUG ANTAGONISM; LONG TERM CARE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; DRUG COSTS; ENGLAND; FAMILY PRACTICE; FEMALE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROTON PUMPS;

EID: 0032589694     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Office of Health Economics. Health expenditures in the UK. London: HMSO, 1996.
2. Rubin GP. Contractor B, Bramble MG. The use of long-term acid suppression therapy. Br J Clin Pract 1995; 49: 119-120.
3. Johannessen T, Peterson H, Kristensen P, et al. Cimetidine on-demand in dyspepsia: experience with randomized controlled single-subject trials. Scand J Gastroenterol 1992; 27: 189-195.
4. Buetow SA, Sibbald B, Cantrill JA, et al. Prevalence of potentially inappropriate long-term prescribing in general practice in the UK, 1980-95: a systematic literature review. BMJ 1996; 313: 1371-1374.
5. Howie JGR. Trends in general practice. London: RCGP, 1977.
6. Zermansky AG. Who controls repeats? Br J Gen Pract 1996; 46: 643-647.
7. Monthly index of medical specialities (MIMS). London: Haymarket Publications, 1998.
8. Hungin APS, Thomas PR, Bramble MG, et al. What happens to patients following open access endoscopy? An outcome study from general practice. Br J Gen Pract 1994; 44: 519-521.
9. Kuipers EJ, Lundell L, Klinkenberg-Knoll EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux oesophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-1022.
10. Dehn TCB, Shepherd SA, Colin-Jones D, et al. Double blind comparison of omeprazole (40 mg OD) versus cimetidine (400 mg QID) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24-hour pH monitoring. Gut 1990; 31: 509-513.
11. Sandmark S, Carlsson R, Fausa O, et al. Omeprazole or ranitidine in reflux oesophagitis. Scand J Gastroenterol 1988; 23: 625-632.
12. Hungin APS, Gunn SD, Bate CM, et al. A comparison of the efficacy of omeprazole 20 mg once daily with ranitidine 150 mg BD in the relief of gastro-oesophageal reflux disease. Br J Clin Res 1993; 4: 73-88.
13. Heading RC. Long-term management of gastro-oesophageal reflux disease. Scand J Gastroenterol 1995; 30(213): 25-30.
14. Kuster E, Ros E, Toledo-Pimental V, et al. Predictive factors in the long-term outcome in gastro-oesophageal reflux disease: six year follow-up of 107 patients. Gut 1994; 35: 8-14.
15. Schindlebeck NE, Klauser AG, Berghammer G, et al. Three year follow-up of patients with gastro-oesophageal reflux disease. Gut 1992; 33: 1016-1019.
16. Richter JE. Surgery for reflux disease - reflections of a gastroenterologist. N Engl J Med 1992; 326: 825-827.